Featured Research

from universities, journals, and other organizations

Study shows promise of molecular screening for gynecologic cancers, commentary writers state

Date:
January 9, 2013
Source:
Dana-Farber Cancer Institute
Summary:
A new study that proposes a three-in-one test for gynecologic cancers underscores the promise of molecular screening for early detection of endometrial and ovarian cancers, but also suggests that such tests are not yet ready for clinical use. Andrea Myers, MD, PhD, of Dana-Farber Cancer Institute, a co-author of the commentary on the study, says the test is an important step in that direction.

A new study that proposes a three-in-one test for gynecologic cancers -- combining a traditional Pap smear for cervical cancer with a DNA test for gene mutations linked to endometrial and ovarian cancer -- underscores the promise of molecular screening for early detection of endometrial and ovarian cancers, but also suggests that such tests are not yet ready for clinical use, write the authors of a commentary in this week's issue of Science Translational Medicine.

"Pap smears have had a tremendous impact in reducing the rate of cervical cancer in the United States," says Andrea Myers, MD, PhD, of Dana-Farber Cancer Institute, a co-author of the commentary on the study. "The lack of an equally effective screening test for women at high risk for endometrial or ovarian cancer has created a great deal of interest in developing tests that could identify these cancers by their genetic 'signature' -- the collection of specific mutations within them. This new study is an important step in that direction."

The study, led by Isaac Kinde and Luis Alberto Diaz, MD, of Johns Hopkins Kimmel Cancer Center, used advanced DNA sequencing technology to look for mutations in 12 genes associated with endometrial or ovarian cancer in cells collected for Pap tests. In Pap samples from women known to have endometrial or ovarian cancer, the screening test -- dubbed "Papgene" -- often found one or more of the mutations. The samples from women without cancer, by contrast, showed no mutations.

Myers notes that the test proved to be highly sensitive for endometrial cancer: every sample from women known to have the disease tested positive for mutations. However, it captured only 40 percent of patients known to have ovarian cancer -- a disease for which there is a particularly urgent need for an early-detection test.

While Papgene didn't find mutations in women without cancer, the test was performed on only 19 samples. Much larger numbers will be needed to ensure the test doesn't mistakenly indicate cancer where none exists, Myers remarked.

"The DNA sequencing technologies that have changed our understanding of the molecular nature of cancer are beginning to be explored for clinical usefulness, and this study is a good example," says Myers. "It's clear that putting a screening technique to the test requires just as much rigor as the basic science discovery process itself."

The commentary's other co-authors are Shannon Westin, MD, MPH, and Gordon Mills, MD, PhD, of the University of Texas MD Anderson Cancer Center.


Story Source:

The above story is based on materials provided by Dana-Farber Cancer Institute. Note: Materials may be edited for content and length.


Journal References:

  1. I. Kinde, C. Bettegowda, Y. Wang, J. Wu, N. Agrawal, I.-M. Shih, R. Kurman, F. Dao, D. A. Levine, R. Giuntoli, R. Roden, J. R. Eshleman, J. P. Carvalho, S. K. N. Marie, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, L. A. Diaz. Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers. Science Translational Medicine, 2013; 5 (167): 167ra4 DOI: 10.1126/scitranslmed.3004952
  2. S. N. Westin, G. B. Mills, A. P. Myers. Repurposing the Pap Smear: One Step Closer to Gynecologic Cancer Screening. Science Translational Medicine, 2013; 5 (167): 167ps1 DOI: 10.1126/scitranslmed.3005411

Cite This Page:

Dana-Farber Cancer Institute. "Study shows promise of molecular screening for gynecologic cancers, commentary writers state." ScienceDaily. ScienceDaily, 9 January 2013. <www.sciencedaily.com/releases/2013/01/130109185655.htm>.
Dana-Farber Cancer Institute. (2013, January 9). Study shows promise of molecular screening for gynecologic cancers, commentary writers state. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2013/01/130109185655.htm
Dana-Farber Cancer Institute. "Study shows promise of molecular screening for gynecologic cancers, commentary writers state." ScienceDaily. www.sciencedaily.com/releases/2013/01/130109185655.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

More Coverage


Scientists Use Pap Test Fluid to Detect Ovarian, Endometrial Cancers

Jan. 9, 2013 Using cervical fluid obtained during routine Pap tests, scientists have developed a test to detect ovarian and endometrial cancers. In a pilot study, the “PapGene” test, which relies on genomic ... read more
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins